Alfred Sandrock Insider Profile

4 Followers
Alfred Sandrock, Head of Research & Development at Biogen, holds 441.82K shares in Voyager Therapeutics (Ticker: VYGR), holds 10.17K shares in Biogen (Ticker: BIIB), holds 0.00 shares in Neurocrine (Ticker: NBIX).
tipranks
Alfred Sandrock

Alfred Sandrock
Biogen (BIIB)
Head of Research & Development

Ranked #22,425 out of 100,956 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+18.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
55.17%
44.83%
0.00%
A breakdown of Alfred Sandrock's holdings

Insider Roles

Voyager Therapeutics
(VYGR)
President & CEO, Director
Biogen
(BIIB)
Head of Research & Development
Neurocrine
(NBIX)
Director
Roles that Alfred Sandrock holds in companies

Most Profitable Insider Trade

Stock:
Voyager Therapeutics
(VYGR)
Rating:Informative Sell
Date:Apr 03, 2024 - Apr 03, 2025
Return:+54.40%
The most profitable trade made by Alfred Sandrock

Alfred Sandrock's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Biogen
Jun 09, 2021
Head of Research & Development
Uninformative Sell
3.38M
$1.53M
Voyager Therapeutics
Feb 24, 2025
President & CEO, Director
Uninformative Buy
$1.88M
Neurocrine
Director
$0.00
List of latest transactions for each holding click on a transaction to see Alfred Sandrock's performance on stock

Alfred Sandrock insider profile FAQ

What is the percentage of profitable transactions made by Alfred Sandrock?
The percentage of profitable transactions made by Alfred Sandrock is 50%.
    What is the average return per transaction made by Alfred Sandrock?
    The average return per transaction made by Alfred Sandrock is 18.60%.
      What stocks does Alfred Sandrock hold?
      Alfred Sandrock holds: BIIB, VYGR, NBIX stocks.
        What was Alfred Sandrock’s latest transaction?
        Alfred Sandrock latest transaction was an Uninformative Buy of ―.
          What was Alfred Sandrock's most profitable transaction?
          Alfred Sandrock’s most profitable transaction was an Informative Sell of VYGR stock on April 3, 2024. The return on the trade was 54.40%.
            What is Alfred Sandrock's role in Biogen?
            Alfred Sandrock's role in Biogen is Head of Research & Development.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.